| |
|
|
| |
Transdermal Pain Management to 2015
Markets, Demand Factors, Opportunities and
Forecasts
|
Publication: Dec 2010
Product Code: TPM324K
|
As life expectancy in the developed world increases and
populations age, the incidence and associated morbidity of
chronic and acute pain is increasing and placing a higher
level of emphasis on pain management as a quality-of-life
issue for patients and their families. Responding to this
trend, drug developers are increasingly turning to
transdermal formulations of pain management drugs. Because
it has the potential to improve drug therapy compliance,
transdermal delivery addresses a key healthcare issue – one
that is particularly problematic in aging populations and
developing economies. Currently approved transdermal pain
products include narcotics, NSAIDs, and topical anesthetics.
These patches and gels will encounter competition from
development-stage transdermal formulations for a number of
pain medications presently being marketed in oral or
parenteral form. Several of these development programs
involve international partnerships designed to take
advantage of perceived opportunities in regional markets. |
|
Highlights |
· Analyzes and evaluates
the global market opportunity for transdermal pain
management and assesses the probable impact of evolving
regulatory, economic and demand factors
· Assesses transdermal
products approved or in development for the delivery of
therapeutic pain management drugs
· Provides detailed
descriptions of pain management treatment segments,
market factors, and business strategies
· Forecasts transdermal
pain management product demand to 2012 by geographic
region and product segment
· Profiles sector companies,
their product development activities,
supply chain partners, business
strategies, and collaboration partners
|
|
Summary of Contents |
Executive Summary
Scope and Definitions
The Current Pain Management Picture
Unmet Needs
in Pain Management
The Opportunity for
Transdermal Delivery of Pain Drugs
The Pain
Management Market Opportunity
Evolution in
Pain Management Guidelines
Regional Factors in
Pain Management Practice
Pain Management Demand
Drivers
Competitive Landscape
Factors
Limiting Growth
Transdermal Drug Delivery
Dynamics
Transdermal Pain Management Patches
Pain Patch Technology & Architectures
Transdermal
Patch Manufacturing and Packaging
Patch Economics
Passive vs Active Delivery Systems
Transdermal
Pain Management Gels
Transdermal Formulations
IP and Proprietary Technology
Limitations of
Topical Gels
Transdermal Pain Management
Product Assessments and Market Prospects
FDA
Approved Transdermal Pain Management Products
Narcotic
NSAIDs
Local Anesthetic
Non-FDA
Approved Commercial Transdermal Pain Management
Products
Narcotic
NSAIDs
Local Anesthetic
Development-Stage Transdermal Pain Management
Products
Narcotic
NSAID
Other Drug Classes
Transdermal Pain Management Market Factors
Regional Regulations
Clinical Trials
Quality and Reliability
Indications Prescribing
Guidelines and Off-Label Prescribing
Managed Care
and Payor Initiatives
Rx-to-OTC Switching
Skin
Patch Revenue Models
Market Forecasts
Forecasts by Region
Forecasts by Drug Class
Forecasts by Delivery Form Factor
Market Share
Data
Market Participant Profiles
|
|
|
|
|
